PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Tegretol
Presentation Product Chemical substance Chapter Items dispensed
Tegretol Prolonged Release 200mg tablets
0408010C0BBAEAG
Tegretol Carbamazepine Central Nervous System 72,564
Tegretol Prolonged Release 400mg tablets
0408010C0BBAFAH
Tegretol Carbamazepine Central Nervous System 70,207
Tegretol 200mg tablets
0408010C0BBABAC
Tegretol Carbamazepine Central Nervous System 50,486
Tegretol 100mg tablets
0408010C0BBAAAB
Tegretol Carbamazepine Central Nervous System 40,763
Tegretol 400mg tablets
0408010C0BBACAD
Tegretol Carbamazepine Central Nervous System 24,463
Tegretol 100mg/5ml liquid (Novartis)
0408010C0BBADAP
Tegretol Carbamazepine Central Nervous System 11,924
Tegretol 100mg Chewtabs
0408010C0BBAGAJ
Tegretol Carbamazepine Central Nervous System 1
Tegretol 100mg/5ml liquid (Imported)
0408010C0BBAKAP
Tegretol Carbamazepine Central Nervous System 1
Tegretol 125mg suppositories
0408010C0BBAIAU
Tegretol Carbamazepine Central Nervous System No data available
Tegretol 200mg Chewtabs
0408010C0BBAHAK
Tegretol Carbamazepine Central Nervous System No data available
Tegretol 250mg suppositories
0408010C0BBAJAV
Tegretol Carbamazepine Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.